Morphine increases myocardial triacylglycerol through regulating adipose triglyceride lipase S406 phosphorylation

Life Sci. 2021 Oct 15:283:119866. doi: 10.1016/j.lfs.2021.119866. Epub 2021 Aug 2.

Abstract

Aims: Morphine, a commonly used drug for anesthesia, affects lipid metabolism in different tissues, but the mechanism is currently unclear. Adipose triglyceride lipase (ATGL) is the rate-limiting enzyme responsible for the first step of triglyceride (TG) hydrolysis. Here we aim to investigate whether ATGL phosphorylation is involved in morphine-induced TG accumulation.

Main methods: Oil red O staining and TG content analysis were used to detect the effect of morphine on lipid storage. A series of ATGL phosphoamino acid site mutant plasmids were constructed by gene synthesis and transfected to HL-1 cells to evaluate the phosphorylation levels of ATGL phosphoamino acid in morphine-treated HL-1 cells with immunoprecipitation and immunoblotting assay.

Key findings: Morphine acute treatment induced excessive accumulation of TG and decreased the phosphorylation level of ATGL Ser406 in HL-1 cells. Of note, the phosphorylation positive mutation of ATGL Ser406 to aspartic acid effectively reversed morphine-induced excessive accumulation of TG in HL-1 cells.

Significance: This discovery will help to fully understand the lipid regulation function of morphine in a new scope. In addition, it will expand the phosphorylation research of ATGL more comprehensively and provide powerful clues for lipid metabolism regulation.

Keywords: ATGL S406; Cardiomyocytes; Lipid metabolism; Morphine; Phosphorylation.

MeSH terms

  • Animals
  • Cell Line
  • Lipase / metabolism*
  • Male
  • Mice
  • Morphine / pharmacokinetics
  • Morphine / pharmacology*
  • Myocardium / metabolism*
  • Myocardium / pathology
  • Myocytes, Cardiac / metabolism*
  • Myocytes, Cardiac / pathology
  • Phosphorylation / drug effects
  • Triglycerides / biosynthesis*

Substances

  • Triglycerides
  • Morphine
  • Lipase
  • PNPLA2 protein, mouse